Late Metastatic Recurrence of Merkel Cell Carcinoma Nine Years After the Primary Diagnosis

Date
2025-10-08
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Springer Nature
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract

Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer of neuroendocrine origin that has been known to recur and metastasize within the first three years of initial diagnosis. MCC is typically diagnosed with clinicopathologic correlation of a red-purple nodule or flesh colored papule on sun-damaged skin and characteristic immunohistochemical staining. We present a case of a 66-year-old White man who was found to have metastatic MCC over nine years after the initial stage one tumor was diagnosed and treated with Mohs micrographic surgery (MMS) and radiation therapy. This case highlights the importance of defining prognostic biomarkers for each patient with MCC and consideration of extended surveillance beyond the current recommended three years. Clinicians should also be attentive when counseling patients to explain that the risk of late metastasis, although low, is still possible.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Kubicki SL, Forbes Kaprive J, Kwong A, Rivlin D, Emerson CM. Late Metastatic Recurrence of Merkel Cell Carcinoma Nine Years After the Primary Diagnosis. Cureus. 2025;17(10):e94125. Published 2025 Oct 8. doi:10.7759/cureus.94125
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Cureus
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}